Day One Biopharmaceuticals Inc (DAWN) Peer Comparison

$21.53

$0.00 (0.00%)

As on 24-Apr-2026 09:30EDT

Market cap

$2,225 Mln

Revenue (TTM)

$158 Mln

P/E Ratio

--

P/B Ratio

5

Div. Yield

0 %

Edit

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Market cap ($ Mln)	2,225	187
Revenue ($ Mln)	158	--
Net Profit ($ Mln)	-107.32	-80.72
Net Margin (%)	-67.85	--
RoE (%)	-22.74	-33.92
Price to Earnings	--	--
Price-To-Book	5.04	0.50

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Operating Revenue	158.18	0.00
Cost of Revenue	17.21	--
Gross Profit	140.97	--
Operating Expenses	268.72	20.11
Operating Profit (EBIT)	-127.75	-20.11
Other Income	--	--
Profit before Tax	-109.30	-42.10
Provision for Tax	-1.98	-6.19
Profit after Tax (Net Income)	-107.32	-35.92
Minority Interest	--	--
Consolidated Profit	-107.32	--

Liabilities ($ Mln)

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Shareholder's Funds	441.16	397.93
Minority Interest	--	--
Non-Current Liabilities	6.14	117.93
Current Liabilities	60.52	3.29
Total Liabilities	507.83	519.15

Assets ($ Mln)

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Non-Current Assets	22.73	501.76
Current Assets	485.10	17.39
Total Assets	507.83	519.15
Total Debt*	2.79	--
Net Current Assets	424.58	14.10

Cashflow ($ Mln)

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Cash From Operating Activities	-103.76	-16.13
Cash Flow from Investing Activities	174.65	-77.57
Cash from Financing Activities	1.22	107.17
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
ROCE (%)	-22.61	-17.99
ROE (%)	-22.74	-17.99
ROA (%)	-19.68	-13.74
EBIT Margin (%)	--	--
Net Margin (%)	-67.85	--
Cash Profit Margin (%)	--	--

Growth Ratios

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Revenue Growth (%)	0.21	--
EBIT Growth (%)	--	--
Net Profit Growth (%)	-12.38	-194.45
EPS Growth (%)	-0.02	0.82
Book Value Growth (%)	--	--

Valuation Ratios

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Price / Earnings	-8.98	-2.70
Price / Book Value	2.18	0.24
Dividend Yield (%)	--	--
EV/EBITDA	-4.24	-1.90
Market Cap ($ Cr)	--	--

Solvency Ratios

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Debt to Equity	0.01	--
Short term debt to equity ratio	0.00	--
Current Ratio	8.02	5.29
Quick Ratio	7.91	--
Interest Coverage	--	--

Operating Efficiency Ratios

	Day One Biopharmaceuticals Inc (DAWN)	Tharimmune Inc Forgn. Eq (THAR)
Debtors to sales (%)	16.90	--
Asset Turnover	0.29	0.00
Receivable days	46.89	--
Inventory Days	102.37	--
Payable days	74.23	--
Cash Conversion Cycle	75.03	--

Annual
Quarterly